05/13/2024 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024 3:05 PM | Louis Chrystal (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 3:17 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 3:25 PM | BAKER BROS. ADVISORS LP (Filed by) TScan Therapeutics (Subject)
| Form SC 13D/A | |
04/23/2024 3:15 PM | Lynx1 Capital Management LP (Reporting) Nichols Weston (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 8:58 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
|
04/17/2024 5:25 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 5:20 AM | TScan Therapeutics (Subject)
| Form FWP | |
04/16/2024 4:21 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
04/16/2024 3:16 PM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2024 11:15 PM | TScan Therapeutics (Filer)
| Form EFFECT | |
04/10/2024 6:30 AM | TScan Therapeutics (Filer)
| Form 10-K/A | |
04/08/2024 7:17 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 6:30 AM | TScan Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2024 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 3:45 PM | K2 HealthVentures Equity Trust LLC (Filed by) TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024 5:02 AM | Pitango HealthTech Fund I, L.P. (Filed by) TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024 6:45 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) TScan Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024 3:21 PM | Amello Jason (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2023 4:00 PM | BARBERICH TIMOTHY J (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 5:01 PM | Klencke Barbara (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 7:00 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 7:15 AM | TScan Therapeutics (Issuer) TScan Therapeutics (Issuer) Woods Keith (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/08/2023 7:20 AM | TScan Therapeutics (Issuer) TScan Therapeutics (Issuer) Woods Keith (Reporting) Woods Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:30 AM | TScan Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:15 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2023 6:39 PM | Dworak Leiden (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2023 6:31 PM | Dworak Leiden (Reporting) TScan Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/29/2023 7:30 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 3:38 PM | TScan Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2023 5:25 PM | BARBERICH TIMOTHY J (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:01 PM | TScan Therapeutics (Issuer) ZDRAVESKI ZORAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:08 PM | MacBeath Gavin (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:09 PM | Silver Brian M. (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:13 PM | Klencke Barbara (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:14 PM | Gruia Gabriela (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Everybody laughed when he recommended Netflix (Ad) "This Could be Worth Even More than A.I."
Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. |
06/15/2023 5:17 PM | Dorton Katina (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 5:19 PM | Barton Debora (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 3:40 PM | 667, L.P. (Reporting) Baker Bros. Advisors LLC (0001580575) (Reporting) BAKER BROS. ADVISORS LP (Reporting) Baker Brothers Life Sciences LP (Reporting) BAKER FELIX (Reporting) BAKER JULIAN (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 12:25 PM | BlackRock Inc. (Filed by) TScan Therapeutics (Subject)
| Form SC 13G/A | |
06/06/2023 6:53 PM | BARBERICH TIMOTHY J (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 3:45 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) TScan Therapeutics (Subject)
| Form SC 13G | |
06/02/2023 4:33 PM | Lynx1 Capital Management LP (Reporting) Nichols Weston (Reporting) TScan Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/02/2023 4:35 PM | Lynx1 Capital Management LP (Reporting) Nichols Weston (Reporting) TScan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 7:00 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 7:16 AM | TScan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/26/2023 7:12 PM | TScan Therapeutics (Filer)
| Form 424B5 | |
05/26/2023 5:42 AM | TScan Therapeutics (Subject)
| Form FWP | |